Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Globotetraosylceramides are bioactive neutral glycosphingolipids. They are the major glycolipids in human erythrocytes.1 They act as receptors for the Shiga toxins Stx1, Stx2, and Stx2e, the cytotoxic protein pierisin-1, and parvovirus B19.2,3,4 Globotetraosylceramides increase the expression of proteins responsible for enamel deposition, including ameloblastin, amelogenin, and enamelin, in dental epithelial cells and activate the ERK and p38 MAPK signaling pathways.5 Levels of globotetraosylceramides are elevated in fibroblasts from patients with salt and pepper syndrome, a neurocutaneous condition characterized by intellectual disability and hyper- and hypo-pigmented skin.6 This product contains globotetraosylceramides with primarily C24:0, C22:0, and 2-hydroxy C24:0 fatty acyl chains. As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1068]
WARNING This product is not for human or veterinary use.
1. Structure of main globoside of human erythrocytes. J. Biochem. 52(3), 228-229 (1962).
2. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101(2), 252-264 (2009).
3. Identification of glycosphingolipid receptors for pierisin-
4. Parvovirus B19 VLP recognizes globoside in supported lipid bilayers. Virology 456-457, 364-369 (2014).
5. Globoside accelerates the differentiation of dental epithelial cells into ameloblasts. Int. J. Oral Sci. 8(4), 205-212 (2016).
6. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum. Mol. Genet. 23(2), 418-433 (2014).